CLINICAL_TRIALS
research
· 2026-04-06
Clinical Trial Update: A Phase 2A Trial of DT402 for Autism Spectrum Disorder [Phase 2]
Summary
A Phase 2A trial of DT402 for autism spectrum disorder is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Definium Therapeutics US, Inc. | Conditions: Autism Spectrum Disorder, ASD | Phase 2 | Status: RECRUITING